Mutabilis has been selected by the European ENABLE project (European Gram-negative Antibacterial Engine), which aims to improve the development of antibiotics against infections caused by multiresistant Gram-negative bacteria.
READ MOREThe DRIVE-AB project is part of the IMI’s New Drug For Bad Bugs (ND4BB) initiative
READ MOREThe new European AMR plan relies on the “One Health” approach
READ MOREThe Office of Health Economic (UK) has released a report that assess the relevance
READ MOREMutabilis will be represented at the European Congress on Clinical Microbiology and Infectious Diseases (ECCMID) in Vienne from April 22nd to 25th 2017.
READ MOREMutabilis will be represented at the “Superdrugs for Superbugs” conference in London on March 20th and 21st 2017.
READ MOREThe Organization has published its first list of the 12 most worrying pathogens
READ MOREMutabilis will be at the Gordon Research Conferences in Italy.
READ MOREConference on Retrovirus and Opportunistic Infections.
READ MORE